IMAD BITAR MD NPI 1821267998

NPI Information

  • NPI: 1821267998
  • Provider Name: IMAD BITAR, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 104 MILLSAPS DR
    HATTIESBURG, MS
    ZIP 39402
  • Phone: (601) 268-5170

Map and Directions

Get Directions

NPI Details

Imad Bitar, MD is a rheumatology internal medicine in Hattiesburg, MS with 28 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Imad Bitar, MD NPI is 1821267998. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

104 MILLSAPS DR
HATTIESBURG, MS
ZIP 39402-328
Phone: (601) 268-5170
Fax: (601) 268-5179

The NPI 1821267998 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Testing for presence of drug, read by direct observation (HCPCS:80305)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Calcium level, total (HCPCS:82310)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Uric acid level, blood (HCPCS:84550)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection, ibandronate sodium, 1 mg (HCPCS:J1740)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)

The enumeration date for this NPI number is 2/22/2008 and was last updated on 7/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology20107MISSISSIPPIYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
19687191OTHERMISSISSIPPIAETNA
208303857MEDICAIDMISSISSIPPI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.